TEVA
Teva Pharmaceutical Industries
Stand aside — overlapping range behaviour — efficiency ratio 0.07 vs the 0.15 threshold (genuine chop).
Mature Trend
XLV
sector confirmed
1 insider(s)
buy date unknown
55
conviction / 100
+6.7 since 19 Aug
66.4
technical / 100
$0–$0
No trade / watch only · Hard gate breached.
Regime clarity15.5
Sponsorship / positioning10.0
Volatility behaviour18.0
Catalyst alignment (insider)2.0
Cross-asset confirmation9.6
Stand aside — hard gate breached
- Overlapping range behaviour — efficiency ratio 0.07 vs the 0.15 threshold (genuine chop).
Last
38.10
Add above
38.11
Cut below
30.15
50DMA
34.00
200DMA
32.10
TEVA — daily, 14 months
XLV — sector ETF, daily, 14 months
Pillar detail, thesis support and invalidation
Regime clarity
What strengthens the thesis
- price above 200DMA
- 200DMA rising
- 50DMA rising
- partial HH/HL structure
- efficiency ratio 0.07 (overlapping)
- OBV 50d slope +0.084 avg-daily-volumes/bar
- price/volume history is NOT one continuous security — a single 26% session gap. A conversion, large secondary or stock merger changes the share count, so the 200DMA averages two capital structures and OBV sums two different securities. Read this pillar with suspicion.
- no OBV divergence at highs
- OBV fell through last pullback
- last pullback 17.0% deep
- no wide downside expansion bars (30d)
- ATR contracting vs 20d mean
- single insider — no cluster
- net purchase ratio unavailable
- NO CFO purchase in the window — the CFO-specific terms score zero
- no CFO buy to date — recency not scored
- closest sector ETF: XLV
- XLV above rising 200DMA (sector-led)
- XLV vs SPY 6m: -0.0 pts
- stock vs XLV RS (3m/6m avg): -4.1 pts
- A confirmed higher high above 38.11 on expanding OBV.
- Pullbacks that hold the rising 50DMA with flat-to-rising OBV.
- XLV extending its own trend while the stock holds relative strength.
- Loss of the rising 50DMA (34.00) with expanding volatility — reduce.
- Breakdown below the prior structural base (30.15) — exit, no averaging down.
- OBV divergence during a price acceleration — reduce.
- Sector ETF losing its own 200DMA — remove capital regardless of stock behaviour.
- CFO: —
- 0 CFO purchase(s), — total; last filed
- Market cap $44,397,780,992 · 20d avg dollar volume $215,921,132
- No open-market insider transactions found in the lookback window.
5 material events; 2 taken well, 0 badly; last earnings 29 Jul: neutral (+9.6%).
| Session | Filing | Event | Gap | Day | vs SPY | Vol | +5d | Read |
|---|---|---|---|---|---|---|---|---|
| 29 Jul 26 | 8-K · earnings | Results of operations (earnings) | +6.3% | +9.6% | +11.1% | 3.7x | +0.0% | Neutral |
| 29 Jul 26 | 10-Q | Quarterly report | +6.3% | +9.6% | +11.1% | 3.7x | +0.0% | Neutral |
| 28 May 26 | 8-K | Material event | -1.1% | -0.1% | -0.7% | 0.5x | -0.3% | Neutral |
| 29 Apr 26 | 8-K · earnings | Results of operations (earnings); Regulation FD disclosure | +7.5% | +11.9% | +11.9% | 4.6x | +2.7% | Rewarded |
| 29 Apr 26 | 10-Q | Quarterly report | +7.5% | +11.9% | +11.9% | 4.6x | +2.7% | Rewarded |